Vivos (RDGL) Debt Ratio (2010 - 2023)

Vivos (RDGL) reported Debt Ratio of 0.01 for Q3 2023, down 99.99% sequentially from 54.72 in Q1 2019.

Vivos (RDGL) Debt Ratio (2010 - 2023) Analysis & Trends

Vivos (RDGL) has 11 years of Debt Ratio data on file, last reported at 0.01 in Q3 2023.

For the quarter ending Q3 2023, Debt Ratio changed N/A year-over-year to 0.01; the trailing twelve-month figure through Sep 2023 stood at 0.01 (changed N/A YoY), and the FY2018 full-year result was 190.25, changed N/A from the prior year.
Debt Ratio fell to 0.01 in Q3 2023, from 54.72 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 54.72 in Q1 2019 to a low of 0.01 in Q3 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn	0.31
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn	0.32
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn	0.30
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn	0.04
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn	-
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn	0.27
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	0.30
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn	0.30
10	Vivos	27.16 Mn	25.60 Mn	-3,105.00	-

Historic Data

Download Data

Date	Value
Sep 30, 2023	0.01
Mar 31, 2019	54.72
Dec 31, 2018	190.25
Sep 30, 2018	2.75
Mar 31, 2018	58.39
Sep 30, 2017	12.99
Jun 30, 2017	1.02
Mar 31, 2017	15.30
Dec 31, 2016	7.91
Sep 30, 2016	4.30
Jun 30, 2016	4.30
Mar 31, 2016	4.20
Dec 31, 2015	5.04
Sep 30, 2015	12.65
Jun 30, 2015	43.84
Mar 31, 2015	11.76
Dec 31, 2014	49.27
Sep 30, 2014	3.31
Jun 30, 2014	1.88
Mar 31, 2014	1.15